FAABORG PHARMA A/S: Financial statements 2020
CVR: 26190770
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
FAABORG PHARMA A/S (CVR 26190770) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 11,292,076 and a net result of DKK 3,991,734 compared with DKK 713,320 the year before. That is an increase of 74.9% compared with the year before. Equity in the 2020 report amounted to DKK 4,792,913. The solvency ratio was 33.4%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 11,292,076
- Profit/Loss
- DKK 3,991,734
- Equity
- DKK 4,792,913
- Total Assets
- DKK 14,355,464
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 11.3 mio. | 4 mio. | 4.8 mio. | 11 |
| 2019 | - | 6.5 mio. | 713 t. | 801 t. | 11 |
| 2018 | - | 6.8 mio. | 2.1 mio. | 88 t. | 9 |
| 2017 | - | 4.6 mio. | 510 t. | -2 mio. | 8 |
| 2016 | - | 5.4 mio. | 1.2 mio. | -2.5 mio. | 7 |
Official annual report
How creditworthy is FAABORG PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of May 15, 2020, Jan Knudsen has joined the board of directors of FAABORG PHARMA A/S.
As of May 15, 2020, Jonas Rössing has left the board of directors of FAABORG PHARMA A/S.
FAABORG PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 6,457,078, and the net result was DKK 713,320.
About FAABORG PHARMA A/S
FAABORG PHARMA A/S is a Danish company of the type Aktieselskab based in Faaborg, founded in 2001. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Frank Hauken Vibæk. The board consists of Claus Wædeled (chair), Birk Simon Maldonado Andersen and Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 13,336,305 and a net result of DKK 747,032 compared with DKK 1,762,826 the year before. Equity in the 2025 report amounted to DKK 10,503,744.